Latest Partnerships And Agreements News

PLS Group has locked in a two-year offtake agreement with Canmax Technologies for 150,000 tonnes per annum of spodumene concentrate, backed by a $100 million interest-free prepayment and a price floor to protect against market dips.

A handful of healthcare names did the heavy lifting this week, driven by FDA wins, guideline upgrades, and big shifts in sales and cashflow. The flip side: several clinical-stage stocks fell hard as investors stayed picky about near-term proof and funding.

Australian Rare Earths Limited (ASX – AR3) has made significant strides in advancing its Koppamurra Rare Earths Project, securing pilot-scale processing at ANSTO’s new facility and raising $6 million post-quarter to fund development. Concurrently, promising uranium targets have been identified at its Overland Project.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Atomo Diagnostics has locked in exclusive global rights to a novel liver function test that rapidly detects liver injury, expanding its footprint in point-of-care diagnostics. The test, delivered on Atomo’s Pascal platform, targets drug-induced liver injury and chronic liver conditions with significant commercial potential.

Vitrafy Life Sciences has entered a 12-month exclusive partnership with IMV Technologies to integrate cryopreservation technologies, securing up to A$930k in fees and milestone payments.

Nickel Industries has secured a strategic partner in Sphere Corp., which will acquire a 10% interest in the ENC HPAL project and enter into a nickel offtake agreement, marking a significant step into Western aerospace markets.

SPC Global Holdings delivered a transformational FY25 with robust financial results and strategic international growth, setting the stage for a confident 25% EBITDA increase in FY26.

Tungsten Mining NL’s latest scoping study confirms Mt Mulgine as a globally significant critical minerals project with strong financial prospects and strategic positioning amid tightening tungsten supply.

Aumake Limited reported a near-breakeven quarter with strong cash receipts and launched a new health product brand while securing a strategic partnership to expand Australian agricultural exports to China.

Temas Resources has completed its acquisition of ORF Technologies, gaining full ownership of the patented Regenerative Chloride Leach (RCL) technology that promises significant cost and environmental advantages in critical metals processing.

Decidr AI Industries moves to acquire full ownership of Decidr.ai, launches its unified AI platform DecidrOS, and reports robust Q1 FY26 progress with significant capital raising and expanding partnerships.